Edition:
United States

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

5,095JPY
19 Apr 2018
Change (% chg)

-- (--)
Prev Close
¥5,095
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,406,749
52-wk High
¥6,693
52-wk Low
¥4,898

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -71.44 March 19 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 2 2 2
(3) HOLD 5 8 8 8
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.50 2.50 2.50

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 2 410,578.00 411,156.00 410,000.00 --
Year Ending Mar-18 11 1,771,210.00 1,809,940.00 1,723,500.00 1,759,970.00
Year Ending Mar-19 11 1,783,580.00 1,818,500.00 1,685,000.00 1,797,040.00
Earnings (per share)
Quarter Ending Mar-18 2 -71.44 -60.20 -82.68 --
Year Ending Mar-18 11 216.49 248.40 200.50 150.35
Year Ending Mar-19 11 192.83 273.98 141.40 151.37
LT Growth Rate (%) 2 8.59 12.20 4.98 14.34

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 447,897.00 488,152.00 40,255.34 8.99
Quarter Ending Sep-17 438,894.00 433,176.00 5,718.00 1.30
Quarter Ending Jun-17 419,498.00 448,240.00 28,742.50 6.85
Quarter Ending Mar-17 400,854.00 416,205.00 15,350.66 3.83
Quarter Ending Dec-16 449,358.00 465,045.00 15,686.66 3.49

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 410,578.00 410,426.00 413,362.00 413,362.00 --
Year Ending Mar-18 1,771,210.00 1,770,340.00 1,760,630.00 1,758,240.00 1,759,970.00
Year Ending Mar-19 1,783,580.00 1,786,600.00 1,774,590.00 1,774,440.00 1,797,040.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 1 0 1 0
Year Ending Mar-18 1 0 3 1
Year Ending Mar-19 0 1 3 1
Earnings